Perioperative dexamethasone in high-grade gliomas: the short-term benefits and long-term harms

被引:2
作者
Mistry, Akshitkumar M. [1 ]
机构
[1] Univ Louisville, Dept Neurol Surg, Louisville, KY 40292 USA
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词
dexamethasone; glioblastoma; glioma; survival; immunosuppression; NEWLY-DIAGNOSED GLIOBLASTOMA; PREOPERATIVE STEROID USE; MALIGNANT GLIOMA; RISK-FACTORS; T-CELLS; SURVIVAL; TEMOZOLOMIDE; COMPLICATIONS; CHEMOTHERAPY; RADIOTHERAPY;
D O I
10.3389/fonc.2023.1335730
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Dexamethasone has been commonly given to patients with a presumed new GBM in relatively large doses (6-16 mg daily for 1-2 weeks) since the 1960s without any rigorous evidence. This treatment with dexamethasone before the diagnosis and adjuvant therapy makes GBM patients unique compared to other newly diagnosed cancer patients. While dexamethasone may be beneficial, recent studies suggest that this potent immunosuppressant with pleiotropic effects is harmful in the long term. This perspective article summarizes the disadvantages of perioperative dexamethasone from multiple facets. It concludes that these growing data mandate rigorously testing the benefits of using perioperative dexamethasone.
引用
收藏
页数:6
相关论文
共 77 条
  • [1] Preoperative steroid use and the incidence of perioperative complications in patients undergoing craniotomy for definitive resection of a malignant brain tumor
    Alan, Nima
    Seicean, Andreea
    Seicean, Sinziana
    Neuhauser, Duncan
    Benzel, Edward C.
    Weil, Robert J.
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2015, 22 (09) : 1413 - 1419
  • [2] Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group
    Arvold, Nils D.
    Armstrong, Terri S.
    Warren, Katherine E.
    Chang, Susan M.
    DeAngelis, Lisa M.
    Blakeley, Jaishri
    Chamberlain, Marc C.
    Dunbar, Erin
    Loong, Herbert H.
    Macdonald, David R.
    Reardon, David A.
    Vogelbaum, Michael A.
    Yuan, Ying
    Weller, Michael
    van den Bent, Martin
    Wen, Patrick Y.
    [J]. NEURO-ONCOLOGY, 2018, 20 (07) : 897 - 906
  • [3] Causes of death in glioblastoma: insights from the SEER database
    Best, Benjamin
    Nguyen, Ha S.
    Doan, Ninh B.
    Gelsomino, Michael
    Shabani, Saman
    Ahmadi Jazi, Ghazaleh
    Sadati, Mohsen
    Sheikh, Sarvenaz
    Adl, Farzad H.
    Taqi, Muhammad A.
    Mortazavi, Martin M.
    [J]. JOURNAL OF NEUROSURGICAL SCIENCES, 2019, 63 (02) : 121 - 126
  • [4] Preoperative statin use is not associated with improvement in survival after glioblastoma surgery
    Bhaysar, S.
    Hagan, K.
    Arunkumar, R.
    Potylchansky, Y.
    Grasu, R.
    Dang, A.
    Carlson, R.
    Cowels, C.
    Arnold, B.
    Rahlfs, T. F.
    Lipski, I.
    Walsh, C.
    Nguyen, A. T.
    Feng, L.
    Cata, J. P.
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2016, 31 : 176 - 180
  • [5] Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
    Bouffet, Eric
    Larouche, Valerie
    Campbell, Brittany B.
    Merico, Daniele
    de Borja, Richard
    Aronson, Melyssa
    Durno, Carol
    Krueger, Joerg
    Cabric, Vanja
    Ramaswamy, Vijay
    Zhukova, Nataliya
    Mason, Gary
    Farah, Roula
    Afzal, Samina
    Yalon, Michal
    Rechavi, Gideon
    Magimairajan, Vanan
    Walsh, Michael F.
    Constantini, Shlomi
    Dvir, Rina
    Elhasid, Ronit
    Reddy, Alyssa
    Osborn, Michael
    Sullivan, Michael
    Hansford, Jordan
    Dodgshun, Andrew
    Klauber-Demore, Nancy
    Peterson, Lindsay
    Patel, Sunil
    Lindhorst, Scott
    Atkinson, Jeffrey
    Cohen, Zane
    Laframboise, Rachel
    Dirks, Peter
    Taylor, Michael
    Malkin, David
    Albrecht, Steffen
    Dudley, Roy W. R.
    Jabado, Nada
    Hawkins, Cynthia E.
    Shlien, Adam
    Tabori, Uri
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (19) : 2206 - +
  • [6] Pre-surgery immune profiles of adult glioma patients
    Bracci, Paige M.
    Rice, Terri
    Hansen, Helen M.
    Francis, Stephen S.
    Lee, Sean
    McCoy, Lucie S.
    Shrestha, Pavan P.
    Warrier, Gayathri
    Clarke, Jennifer L.
    Molinaro, Annette M.
    Taylor, Jennie W.
    Wiencke, John K.
    Wrensch, Margaret R.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2022, 159 (01) : 103 - 115
  • [7] Corticosteroids use and neurocognitive functioning in patients with recurrent glioblastoma: Evidence from European Organization for Research and Treatment of Cancer (EORTC) trial 26101
    Caramanna, Ivan
    de Kort, Julie M.
    Brandes, Alba A.
    Taal, Walter
    Platten, Michael
    Idbaih, Ahmed
    Frenel, Jean Sebastien
    Wick, Wolfgang
    Preetha, Chandrakanth Jayachandran
    Bendszus, Martin
    Vollmuth, Philipp
    Reijneveld, Jaap C.
    Klein, Martin
    [J]. NEURO-ONCOLOGY PRACTICE, 2022, 9 (04) : 310 - 316
  • [8] Context-Dependent Effect of Glucocorticoids on the Proliferation, Differentiation, and Apoptosis of Regulatory T Cells: A Review of the Empirical Evidence and Clinical Applications
    Cari, Luigi
    De Rosa, Francesca
    Nocentini, Giuseppe
    Riccardi, Carlo
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (05)
  • [9] Dexamethasone in Glioblastoma Multiforme Therapy: Mechanisms and Controversies
    Cenciarini, Marta
    Valentino, Mario
    Belia, Silvia
    Sforna, Luigi
    Rosa, Paolo
    Ronchetti, Simona
    D'Adamo, Maria Cristina
    Pessia, Mauro
    [J]. FRONTIERS IN MOLECULAR NEUROSCIENCE, 2019, 12
  • [10] The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme
    Chambless, Lola B.
    Kistka, Heather M.
    Parker, Scott L.
    Hassam-Malani, Laila
    McGirt, Matthew J.
    Thompson, Reid C.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2015, 121 (02) : 359 - 364